References
- Mojardin L, Botet J, Moreno S, Salas M. Chromosome segregation and organization are targets of 5'-Fluorouracil in eukaryotic cells. Cell Cycle 2015; 14: 206–18; PMID:25483073; http://dx.doi.org/10.4161/15384101.2014.974425
- Heidelberger C, Chaudhuri NK, Danneberg P, Mooren D, Griesbach L, Duschinsky R, Schnitzer RJ, Pleven E, Scheiner J. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 1957; 179: 663–6; PMID:13418758; http://dx.doi.org/10.1038/179663a0
- Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003; 3: 330–8; PMID:12724731; http://dx.doi.org/10.1038/nrc1074
- Morgan MA, Shilatifard A. Chromatin signatures of cancer. Genes Dev 2015; 29: 238–49; PMID:25644600; http://dx.doi.org/10.1101/gad.255182.114